[144] Cencora, Inc. SEC Filing

Rhea-AI Filing Summary

Cencora, Inc. (Form 144) – A notice of proposed insider sale has been filed for 14,579 common shares with an estimated aggregate market value of $4,266,106.98. The sale is expected to be executed on 06/24/2025 through Fidelity Brokerage Services on the NYSE.

The filing discloses that Cencora has 193,823,487 shares outstanding; the planned transaction therefore represents roughly 0.0075 % of the company’s total shares, indicating an immaterial effect on share count but providing insight into insider behavior.

Acquisition background:

• 2,000 shares acquired via restricted-stock vesting on 09/30/2023 (compensation).
• 12,579 shares acquired via option exercise dated 06/24/2025 (cash payment).

Recent insider activity (past three months):

• 03/25/2025 – 14,578 shares sold for $3,928,916.78
• 04/22/2025 – 14,579 shares sold for $4,108,507.99
• 05/20/2025 – 14,578 shares sold for $4,283,599.52

Total recent disposals equal 43,735 shares and $12.32 million in gross proceeds.

No relationship to the issuer is specified in the excerpt, and no Rule 10b5-1 plan adoption date is provided. The filer certifies that no undisclosed material adverse information is known at the time of filing.

Positive

• None.

Negative

• Continued insider selling: Proposed sale of 14,579 shares ($4.27 M) follows three recent sales totalling 43,735 shares and $12.32 M, potentially signaling waning insider confidence.

Insights

Securities Analyst

TL;DR: Fourth consecutive monthly insider sale; 14,579 shares worth $4.27 M planned, adding to $12.3 M recent disposals—marginal dilution, potential bearish sentiment signal.

Insider selling continues in a predictable monthly cadence, suggesting a possible programmed liquidation strategy. While the absolute share count is negligible at 0.0075 % of outstanding stock, the pattern—four filings in as many months—may be perceived negatively by momentum and sentiment-driven investors. Aggregate proceeds of roughly $16.6 M over four transactions underscore a deliberate exit pace. No operational or financial metrics accompany the filing, so there is no direct read-through to fundamentals; however, repeated insider sales can weigh on market psychology, especially absent offsetting insider purchases or clear 10b5-1 disclosure.

Corporate Governance Expert

TL;DR: Routine Form 144 shows sustained insider monetization; lack of 10b5-1 details may raise governance transparency questions.

Form 144 filings are purely disclosure documents, but investors watch the cadence and size of insider transactions for governance cues. Here, the filer’s continued monthly sales, coupled with an undisclosed relationship field and no visible 10b5-1 plan date, could prompt scrutiny from governance-focused funds. The sale size remains immaterial to float, limiting mechanical impact, yet persistent disposals without context can erode perceived alignment between management and shareholders. No regulatory concerns appear; the attestation that no non-public adverse information exists is standard.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	14579	4266106.98	193823487	06/24/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/30/2023	Restricted Stock Vesting	Issuer			2000	09/30/2023	Compensation
Common	06/24/2025	Options Granted - 11/13/2019	Issuer			12579	06/24/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Steven Collis 1 West First Avenue Conshohocken PA 19428-1800	Common	03/25/2025	14578	3928916.78
Steven Collis 1 West First Avenue Conshohocken PA 19428-1800	Common	04/22/2025	14579	4108507.99
Steven Collis 1 West First Avenue Conshohocken PA 19428-1800	Common	05/20/2025	14578	4283599.52

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Cencora (COR) disclose in the latest Form 144?

The company reported a proposed insider sale of 14,579 common shares valued at $4.27 million, expected on 06/24/2025.

How large is the planned share sale relative to Cencora’s outstanding shares?

The 14,579 shares represent approximately 0.0075 % of the 193.8 million shares outstanding.

Has the same insider sold Cencora stock recently?

Yes. The filer sold 43,735 shares across three transactions between March and May 2025, generating $12.32 million in proceeds.

What is the market value of the shares to be sold on 06/24/2025?

The aggregate market value stated in the filing is $4,266,106.98.

Were the shares acquired through compensation or purchase?

The filing notes 2,000 shares from restricted-stock vesting and 12,579 shares from an option exercise paid in cash.